Opinion EDITORIAL Howard K. Koh, MD, MPH; Alan C. Geller, RN, MPH; Tyler J. VanderWeele, PhD In any year, keeping track of new health trends can be diffi- constitutes 4% of the globe’s population, ranks first in the world cult. But this year, the dynamic nature of coronavirus disease in total pandemic deaths (19% of the global total), with the 12th 2019 (COVID-19) has made clarity almost impossible. De- worst (as of December 14) COVID-19 cumulative mortality rates of all countries. clines in mortality, after daily COVID-19–related deaths peaked The rising deaths have come despite heroic last spring, initially fueled efforts by frontline health care professionals, advances in hos- hope that the worst was over. pital-based COVID-19 care, and therapeutic agents newly au- Viewpoint page 123 But following a summer in- thorized by the US Food and Drug Administration such as crease in deaths, trends have accelerated even faster. This fall, monoclonal antibody treatments, remdesivir, and dexameth- a million new cases of severe acute respiratory syndrome coro- asone. Notably, mortality statistics fail to capture the full dev- navirus 2 (SARS-CoV-2) infection, which previously had in- astation of COVID-19–related morbidity, involving not only creased monthly, began appearing weekly; as of
JAMA – American Medical Association
Published: Jan 12, 2021
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera